share_log

Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024

Benzinga ·  Sep 27 14:50
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment